Adlai Nortye Ltd.

NASDAQ:ANL

Biotechnology

Healthcare
$9.48 -1.07%

-$0.11 today

Market cap
$503.20M
Beta
0.99
P/E (TTM)
-3.0
EPS (TTM)
-$3.33
52W Low $0.88High $17.25

Volume 0.29M

Average 0.35M

Returns on capital

Adlai Nortye Ltd. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

426.9%

avg 29.5%

ROIC

-197.7%

avg -235.2%

ROA

-103.2%

avg -103.1%

Analysis

ROE is currently the strongest return metric at 426.9% versus its period average of 29.5%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Zhiyong Yu

Vice President of Operations————

Christopher Liu

Head of Investor Relations & Public Relations————

Xiaofeng Ye

Chief Financial Officer—47147.76K0.28%

Ngai Chiu Tse

President & Head of Research & Development—59——

Nanhai He

Head of Discovery————

Donghui Yang

Chairman of the Greater China Region————

Yang Lu

Co- Founder, Chief Executive Officer & Chairman—47100.00K0.19%

Chen Yang

Head of HR & Administration & Government Affairs————

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 1, 2029.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

7

$411,191.33

Net Transaction Value

−$411,191.33

Net selling

Most Active

Ji Ping

4 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 30, 26

Ji Ping

Direct

Sell$80.2K
Sep 30, 26

Ji Ping

Direct

Sell$79.8K
Sep 29, 26

Ji Ping

Direct

Sell$3.4K
Sep 22, 26

Ji Ping

Direct

Sell$83.2K
Aug 26, 26

Ye Xiaofeng

Direct

Sell$80.8K
Aug 24, 26

Ye Xiaofeng

Direct

Sell$83.9K
May 13, 26

LU YANG

Direct

Sell$131.8

Summary

Insiders reported 0 buys worth $0.00 and 7 sells worth $411,191.33 over the last 12 months. That adds up to net selling of $411,191.33. Ji Ping was the most active insider with 4 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
+37.0% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Forward estimates point to Revenue at +37.0% (5yr), giving you a quick read on expected growth from here.

Competitors

Who does Adlai Nortye Ltd. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ANL's management, answered from reported figures.

Who manages ANL?

Adlai Nortye Ltd. (ANL) lists 8 active executives. The top listed executive is Zhiyong Yu, Vice President of Operations.

Are ANL insiders buying or selling?

Recent insider activity shows net buying of $9.55M.